Opus Genetics, Inc.
IRD · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $14.2M | $11.0M | +29.2% |
| Operating income | −$38.6M | −$62.1M | +37.8% |
| Net income | −$49.6M | −$57.5M | +13.8% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $1.10M | $3.10M | −64.5% |
| Operating income | −$19.2M | −$8.30M | −131% |
| Net income | −$46.5M | −$17.5M | −166% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Opus Genetics's revenue in FY2025?
- $14.2M in FY2025 (Fiscal year ended Dec 31, 2025), +29.2% vs $11.0M a year earlier, per its 10-K filed Mar 2026.
- Was Opus Genetics profitable in FY2025?
- No: net income was −$49.6M and operating income −$38.6M in FY2025.
- What was Opus Genetics's revenue in Q3 2026?
- $1.10M (−64.5% vs a year earlier), per its Form 10-Q filed Nov 10, 2026.